3370 results for «2024»
3370 results
How the latest recommendations on MINOCA can impact our practice
14 May 2024 – From EuroPCR 2024
Join Vijay Kunadian and Salvatore Brugaletta as they talk about the latest ESC guidelines for MINOCA (Myocardial Infarction with Non-Obstructive Coronary Arteries). Together, they review the crucial aspects of identifying MINOCA patients, how to diagnose them effectively using available diagnostic tools and the importance of post-treatment...
ShortCut leads the way for leaflet modification
14 May 2024 – From EuroPCR 2024
Check out this interview with Philippe Genereux, Danny Dvir and Susheel Kodali, where they discuss the ShortCut trial. Learn about the ShortCut device, the first tool for splitting leaflets in valve-in-valve procedures. Hear key insights, including the dual splitting technique, comparisons between BASILICA and ShortCut, and...
AID-ANGIO study: performing ad hoc microvascular assessment during diagnostic coronary angiography
14 May 2024 – From EuroPCR 2024
Christopher Cook interviews Javier Escaned to unravel the AID-ANGIO study, probing its purpose, methodology, and key outcomes. This study aimed to showcase the viability, safety, and diagnostic benefits of performing invasive functional testing ad hoc in managing patients with chronic coronary syndromes.
This interview was filmed at...
Early detection and treatment of aortic stenosis
25 Nov 2024 – From PCR London Valves 2024
Want to learn about the latest advancements in the early detection and treatment of aortic stenosis? Mayra Guerrero and Philippe Genereux discuss the benefits of early intervention (even in asymptomatic patients), the optimal timing for treatment and explore how artificial intelligence can enhance diagnosis, particularly in...
How to manage the complexity of multivalve disease?
17 Apr 2025 – From PCR London Valves 2024
Curious about how to manage the complexities of multivalve disease? Tiffany Patterson and Philipp Lurz share their approach to treating patients with multiple valve issues (aortic stenosis, mitral regurgitation, tricuspid regurgitation...) and discuss strategies for deciding which valve to treat first, the challenges of managing these...
What is the optimal TAVI access approach in contemporary practice?
14 May 2025 – From PCR London Valves 2024
What is the optimal TAVI access approach in today’s practice? Ole De Backer and Maarten Vanhaverbeke break down the latest evidence and trends in TAVI access. Watch this video to learn about the dominance of transfemoral access, the role of alternative routes like transcarotid and transaxillary,...
Nurses and Allied Professionals: How to safely discharge your patient post TAVI?
10 Feb 2025 – From PCR London Valves 2024
What does it take to ensure a smooth, safe, and confident discharge for TAVI patients? Sarah Carson and Gemma McCalmont share valuable insights and practical strategies. From pre-assessment planning and early mobilization to managing complications and preparing patients for recovery, this video offers essential tips for...
What do we know about bleeding risk & antithrombotic management after tricuspid valve interventions?
26 Nov 2024 – From PCR London Valves 2024
How do we navigate the thin line between bleeding risk and thrombosis in high-risk patients undergoing tricuspid valve interventions? Marianna Adamo and Fabien Praz explore the latest strategies in anticoagulation, the challenges of managing complex cases and how cutting-edge research is shaping the future of care....
Nurses and Allied Professionals: How does frailty and cognition impact patient selection for TAVI?
26 Nov 2024 – From PCR London Valves 2024
How do frailty and cognitive function shape patient selection for TAVI? Karen Wilson and Lynne Hinterbuchner discuss the essential role of screening and assessment in identifying suitable candidates, highlighting tools like the Edmonton scale and emphasizing the importance of a multidisciplinary approach to prehabilitation.
This interview was...
Insights from real-world and post-market evidence on Tricuspid TEER
26 Nov 2024 – From PCR London Valves 2024
In this video, Mirjam Wild, Tobias Kister, and Jonathan Byrne discuss real-world evidence from transcatheter edge-to-edge repair, focusing on the TriCLASP and PACE registries. These studies evaluate the PASCAL Precision system for tricuspid regurgitation and its impact on clinical practice.
This interview was filmed at PCR London...
TRISCEND II Pivotal Trial : How will TTVR impact the treatment of tricuspid regurgitation?
25 Nov 2024 – From PCR London Valves 2024
In this roundtable discussion, Marianna Adamo, Philipp Lurz, and Sam Dawkins explore the one-year outcomes of the TRISCEND II Pivotal Trial, highlighting its potential to redefine the management of severe tricuspid regurgitation. They delve into the trial’s impact on patients’ quality of life, examine its limitations,...
Drug-coated balloon PCI for de novo lesions: when and how?
15 May 2024 – From EuroPCR 2024
Michael Haude and Michael Lee discuss various aspects of DCB PCI, emphasizing lesion preparation, dissection management, and the role of imaging and physiology. They touch upon ongoing studies comparing DCB PCI with DES PCI, consider the duration of DAPT in ACS and non-ACS cases, and explore...
What are the key considerations for first-time TAVI in a patient with long life expectancy?
15 May 2024 – From EuroPCR 2024
Interviewed by Dan Blackman, Philip Maccarthy discusses the rising trend of TAVI in younger patients and emphasizes optimizing first-TAVI procedure outcomes for long-term durability. He highlights considerations such as haemodynamics, low gradient, and minimizing paravalvular leak (PVL), as well as the importance of coronary access and...
When and how to treat the side branch in non-left main bifurcations?
16 May 2024 – From EuroPCR 2024
In this video, Jens Flensted Lassen and Thomas Cuisset discuss the importance of the side branch during bifurcation percutaneous coronary intervention (PCI). They emphasize that while there is no perfect solution for all patients, decisions must be tailored to each individual case, often influenced by the patient's...
Clinical experience with DurAVR THV: a new class, biomimetic TAVI
16 May 2024 – From EuroPCR 2024
Join Azeem Latib, Christopher Meduri, and Nicolas Van Mieghem as they explore the history of cutting-edge tissue science in the TAVI space. Learn about the development of a biomimetic aortic valve design and insights from the DurAVR FIH study on this balloon-expandable platform. Discover the link...
First clinical evidence from a new transcatheter solution utilizing cross-caval anchoring for untreatable TR
16 May 2024 – From EuroPCR 2024
Join Philipp Lurz and Rodrigo Estevez Loureiro as they discuss with Marta Sitges a groundbreaking treatment for tricuspid regurgitation involving the implantation of heterotopic prostheses. They emphasize the harmful effects of backward failure, describe the innovative cross-caval approach, and introduce the Trillium™ and Unica™ devices. This...
Sensor-Guided TAVI using the SavvyWire Pre-Shaped Pressure Guidewire
16 May 2024 – From EuroPCR 2024
In this roundtable discussion, Ole De Backer and Danny Dvir explore the potential of the new SavvyWire to enhance #TAVI procedures by improving safety and efficiency while reducing the need for multiple manipulations. They also highlight how real-time left ventricle monitoring during procedures can lead to...
Focus on Jon DeHaan Foundation Award for Innovation in Cardiology
18 Jun 2024 – From EuroPCR 2024
Join Tom DeHaan, Rishi Puri, and Robert Schwartz as they delve into the history and purpose of the Jon DeHaan Foundation. Learn about the prestigious award's latest winner, the A-FLUX coronary sinus reducer, and the journey that led to this achievement. Discover how recognizing innovative and...
Coronary artery stents - A comprehensive update of the chapter in The PCR Textbook
18 Jun 2024 – From EuroPCR 2024
Watch this discussion between Miklos Rohla and Stephan Windecker as they delve into the newly updated PCR Textbook chapter on stents, the first update in 6 years. This comprehensive resource includes pre-clinical and clinical findings, randomized trial evidence, and in-depth technical specs for all current stents....
Bioadaptor RCT 2 years: could we further improve long-term CAD outcomes vs DES?
14 May 2024 – From EuroPCR 2024
Follow this exchange between Antonio Colombo, Stefan Verheye, and Davide Capodanno as they discuss the past, present, and future of drug-eluting stents. They address the current limitations, emphasizing the issue of vessel caging, and suggest improvements, particularly highlighting the new Bioadaptor with uncaging bioresorbable elements that...
